Articles published by Exelixis, Inc.
Exelixis Advances Board Refreshment Plan
April 13, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis Reiterates Commitment to Shareholder Value Creation
April 05, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis Announces $550 Million Share Repurchase Program
March 20, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
February 07, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023
January 24, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis Announces Update on Patent Litigation with MSN Laboratories
January 19, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis to Present at the Virtual JMP Securities Hematology and Oncology Summit on December 7, 2022
November 30, 2022
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis Announces Third Quarter 2022 Financial Results and Provides Corporate Update
November 01, 2022
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Exelixis to Release Third Quarter 2022 Financial Results on Tuesday, November 1, 2022
October 18, 2022
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.